300 related articles for article (PubMed ID: 31197901)
1. Accuracy evaluation of automated electrochemiluminescence immunoassay for everolimus and sirolimus compared to liquid chromatography-tandem mass spectrometry.
Lee EJ; Kim HK; Ahn S; Lee W; Kim HS; Chun S; Min WK
J Clin Lab Anal; 2019 Sep; 33(7):e22941. PubMed ID: 31197901
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Abbott ARCHITECT i2000 sirolimus assay and comparison with the Abbott IMx sirolimus assay and an established liquid chromatography-tandem mass spectrometry method.
Johnson-Davis KL; De S; Jimenez E; McMillin GA; De BK
Ther Drug Monit; 2011 Aug; 33(4):453-9. PubMed ID: 21743377
[TBL] [Abstract][Full Text] [Related]
3. Comparison of everolimus QMS immunoassay on Architect ci4100 and liquid chromatography/mass spectrometry: lack of agreement in organ-transplanted patients.
Hoffer E; Kurnik D; Efrati E; Scherb I; Karasik M; Ring G; Bentur Y
Ther Drug Monit; 2015 Apr; 37(2):214-9. PubMed ID: 25162218
[TBL] [Abstract][Full Text] [Related]
4. Measurement of sirolimus concentrations in human blood using an automated electrochemiluminescence immunoassay (ECLIA): a multicenter evaluation.
Stove V; Ramos PA; Wallemacq P; Vogeser M; Schuetzenmeister A; Schmiedel C; Shipkova M
Clin Chem Lab Med; 2018 Apr; 56(5):764-775. PubMed ID: 29206642
[TBL] [Abstract][Full Text] [Related]
5. Comparison of a stable isotope-labeled and an analog internal standard for the quantification of everolimus by a liquid chromatography-tandem mass spectrometry method.
Heideloff C; Payto D; Wang S
Ther Drug Monit; 2013 Apr; 35(2):246-50. PubMed ID: 23503452
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic drug monitoring of immunosuppressants by liquid chromatography-mass spectrometry.
McShane AJ; Bunch DR; Wang S
Clin Chim Acta; 2016 Feb; 454():1-5. PubMed ID: 26721314
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the interchangeability between the new fully-automated affinity chrome-mediated immunoassay (ACMIA) and the Quantitative Microsphere System (QMS) with a CE-IVD-certified LC-MS/MS assay for therapeutic drug monitoring of everolimus after solid organ transplantation.
Ialongo C; D'alessandro A; Sapio M; Angeloni A; Porzio O
Clin Chem Lab Med; 2023 Jan; 61(2):245-250. PubMed ID: 36330751
[TBL] [Abstract][Full Text] [Related]
8. A Rapid and Simple Liquid-Chromatography-Tandem Mass Spectrometry Method for Measuring 25-Hydroxyvitamin D2 and 25-Hydroxyvitamin D3 in Human Serum: Comparison with Two Automated Immunoassays.
Lee S; Kim JH; Kim SA; Sun YS; Lee A; Park SJ; Kim YT; Lee KR; Kim YJ
Ann Clin Lab Sci; 2016 Dec; 46(6):645-653. PubMed ID: 27993879
[TBL] [Abstract][Full Text] [Related]
9. Multicenter Evaluation of a New Electrochemiluminescence Immunoassay for Everolimus Concentrations in Whole Blood.
Verstraete AG; Rigo-Bonnin R; Wallemacq P; Vogeser M; Schuetzenmeister A; Schmiedel C; Shipkova M
Ther Drug Monit; 2018 Feb; 40(1):59-68. PubMed ID: 29210975
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Drug Monitoring of Everolimus: Comparability of Concentrations Determined by 2 Immunoassays and a Liquid Chromatography Tandem Mass Spectrometry Method.
Shipkova M; Rapp S; Rigo-Bonnin R; Wieland E; Peter A
Ther Drug Monit; 2017 Apr; 39(2):102-108. PubMed ID: 28125504
[TBL] [Abstract][Full Text] [Related]
11. Comparison of blood sirolimus, tacrolimus and everolimus concentrations measured by LC-MS/MS, HPLC-UV and immunoassay methods.
Sallustio BC; Noll BD; Morris RG
Clin Biochem; 2011 Feb; 44(2-3):231-6. PubMed ID: 20970416
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Performance of Laboratory-Developed Liquid Chromatography-Tandem Mass Spectrometry Tests and a Food and Drug Administration-Approved Immunoassay for the Therapeutic Drug Monitoring of Everolimus.
Schniedewind B; Meyer EJ; Christians U
Ther Drug Monit; 2020 Jun; 42(3):421-426. PubMed ID: 32427781
[TBL] [Abstract][Full Text] [Related]
13. Everolimus method comparison between Waters MassTrak™ Immunosuppressants XE (IUO) kit and an in-house laboratory developed LC-MS/MS method in renal transplant patients.
Johnson-Davis KL; Juenke JM; Thomas RL; Bradshaw T
Ann Clin Lab Sci; 2015; 45(1):27-31. PubMed ID: 25696007
[TBL] [Abstract][Full Text] [Related]
14. Rapid estimation of whole blood everolimus concentrations using architect sirolimus immunoassay and mathematical equations: comparison with everolimus values determined by liquid chromatography/mass spectrometry.
Dasgupta A; Moreno V; Balark S; Smith A; Sonilal M; Tejpal N; Van Buren CT
J Clin Lab Anal; 2011; 25(3):207-11. PubMed ID: 21567470
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the New Cyclosporine and Tacrolimus Automated Electrochemiluminescence Immunoassays under Field Conditions.
Toole B; Gechtman C; Dreier J; Kuhn J; Gutierrez MR; Barrett A; Niederau C
Clin Lab; 2015; 61(9):1303-15. PubMed ID: 26554251
[TBL] [Abstract][Full Text] [Related]
16. Performance characteristics of the VIDAS® 25-OH Vitamin D Total assay - comparison with four immunoassays and two liquid chromatography-tandem mass spectrometry methods in a multicentric study.
Moreau E; Bächer S; Mery S; Le Goff C; Piga N; Vogeser M; Hausmann M; Cavalier E
Clin Chem Lab Med; 2016 Jan; 54(1):45-53. PubMed ID: 26124054
[TBL] [Abstract][Full Text] [Related]
17. Is the automated Elecsys tacrolimus assay on the Roche cobas e 602 analyzer an acceptable replacement for a liquid chromatography-tandem mass spectrometry-based assay?
Gant Kanegusuku A; Yeo KJ
Am J Clin Pathol; 2024 Jan; 161(1):97-106. PubMed ID: 37724434
[TBL] [Abstract][Full Text] [Related]
18. Determination of cyclosporine, tacrolimus, sirolimus and everolimus by liquid chromatography coupled to electrospray ionization and tandem mass spectrometry: assessment of matrix effects and assay performance.
Vethe NT; Gjerdalen LC; Bergan S
Scand J Clin Lab Invest; 2010 Dec; 70(8):583-91. PubMed ID: 21039189
[TBL] [Abstract][Full Text] [Related]
19. Two rapid ultra performance liquid chromatography/tandem mass spectrometry (UPLC/MS/MS) methods with common sample pretreatment for therapeutic drug monitoring of immunosuppressants compared to immunoassay.
Tszyrsznic W; Borowiec A; Pawlowska E; Jazwiec R; Zochowska D; Bartlomiejczyk I; Zegarska J; Paczek L; Dadlez M
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jun; 928():9-15. PubMed ID: 23584041
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive drugs in whole blood: validation of a commercially available liquid chromatography/tandem mass spectrometry kit and comparison with immunochemical assays.
Polledri E; Mercadante R; Ferraris Fusarini C; Maiavacca R; Fustinoni S
Rapid Commun Mass Spectrom; 2017 Jul; 31(13):1111-1120. PubMed ID: 28439923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
